Multimodal retinal imaging in the fellow eyes of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

TCTR

Registry ID

TCTR20161115003

Enrollment

135

Registered

2016-11-15

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unilateral PCV and age&#45

Interventions

Fellow eye of unilateral PCV patient who had FFA&#45

ICG&#44

FAF&#44

SD&#45

OCT in both eyes,Fellow eye of unilateral Neovascular age&#45

related macular degeneration patient who had FFA&#45

OCT in both eyes

Screening,Screening

PCV Patients,Neovascular age&#45

related macular degeneration patients

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: PCV and neovascular AMD patients Patient who had definite diagnosis by FFA ICG Patients who had FFA-ICG, FAF, SD-OCT in both eyes

Exclusion criteria

Exclusion criteria: Significant cataract or media opacity Myopic maculopathy Macular hole Thick subfoveal haemorrhage Macular geographic atrophy Previous photodynamic therapy or anti-VEGF used Patient who didn't perform SD-OCT, FAF, ICG in both eyes at the same visit

Design outcomes

Primary

Measure	Time frame
To identified the abnormalities of the fellow eye in PCV patients compared with neovascular AMD 3 years Using multimodal retinal imaging	—

Secondary

Measure	Time frame
None None None	—

Countries

Thailand

Contacts

Public ContactSomanus Thoongsuwan

Siriraj Hospital

-024198037

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Multimodal retinal imaging in the fellow eyes of polypoidal choroidal vasculopathy and neovascular age&#45;related macular degeneration